Zacks Investment Research on MSN
Should you continue to hold Bio-Techne stock in your portfolio?
Bio-Techne TECH continues to expand its portfolio and enter adjacent markets via acquisitions and strategic investments. Strength in international markets underscores the company’s growth potential.
Asianet Newsable on MSN
HCWB stock soars pre-market on positive research results for CAR-T cell therapy
HCW Biologics said its proprietary multi-cytokine fusion protein reagent, HCW9206, offers a cost-effective way to generate ...
Commercialization ready compound supports a new method of generating highly functional human CAR-T cells for treating infectious diseases and ...
In addition to OEM distribution, the collaboration provides flexibility for potential future expansion, which could include Dyadic supplying market-ready products for distribution or licensing ...
Peerless Plumage falls into the second category. For Peerless Plumage, you want to head to Eversong Woods or Harandar. While ...
Making a living brain transparent and watching its neurons fire without disturbing their function-sounds like science fiction ...
Making a living brain transparent and watching its neurons fire without disturbing their function—sounds like science fiction ...
The rise of lithium-ion batteries in electric vehicles and energy storage systems has led to a growing number of retired ...
This little guy might be the highlight of the weekly events for me. Hunting down wayward Magisters and Thornspeakers for a weirdo with a suffering fixation? Holding fancy parties in the woods?
Agilent acquires Biocare for $950M to boost pathology/cancer diagnostics and recurring revenue. Click here to read an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results